Jianming Xu

机构：University of Technology Sydney, Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University · ORCID：0000-0003-4467-6021

发表论文 398 篇 · 总被引 28671 次 · h-index 59

代表论文

• 177Lu-Dotatate versus high-dose long-acting octreotide for the treatment of patients with advanced, grade 1-2, well-differentiated gastroenteropancreatic neuroendocrine tumours (XT-XTR008-3-01): an open-label, randomised, phase III trial (2025 · Annals of Oncology · 被引 5)
• Pembrolizumab with trastuzumab and chemotherapy for HER2-positive advanced gastric cancer: health-related quality-of-life analysis from the randomized KEYNOTE-811 trial (2025 · ESMO Open · 被引 4)
• Current progress in neoantigen-based dendritic cell vaccines for solid tumors (2025 · Cancer Biology and Medicine · 被引 4)
• Preclinical Development and a Case Report of a Nanobody-Based CLDN18.2 CAR-T IMC002 with Reduced On-Target Off-Tumor Toxicity (2025 · Molecular Cancer Therapeutics · 被引 2)
• Association between the serum albumin-to-creatinine ratio and 28-day all-cause mortality in sepsis: a retrospective cohort study (2025 · Frontiers in Medicine · 被引 2)
• Radiomics for differentiating ruptured intracranial aneurysms: overview, methodological quality evaluation using METRICS and RQS, and feature transportability validation using independent multi-center dataset (2026 · European Radiology · 被引 1)